- Home
- CSGP vs MDGL Comparison
CSGP vs MDGL Comparison
Compare CSGP & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSGP | MDGL |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 11.1B |
| IPO Year | 1998 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CSGP | MDGL |
|---|---|---|
| Price | $30.13 | $509.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 12 |
| Target Price | $60.57 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 6.3M | 245.0K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.32 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $965,230,000.00 | $180,133,000.00 |
| Revenue This Year | $19.71 | $58.39 |
| Revenue Next Year | $12.40 | $48.55 |
| P/E Ratio | $3,042.00 | ★ N/A |
| Revenue Growth | ★ 15.23 | N/A |
| 52 Week Low | $30.38 | $279.33 |
| 52 Week High | $97.43 | $615.00 |
Technical Indicators
Market Signals| Indicator | CSGP | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 29.42 | 55.19 |
| Support Level | N/A | $498.59 |
| Resistance Level | $34.84 | $545.29 |
| Average True Range (ATR) | 1.60 | 18.89 |
| MACD | -0.19 | 3.16 |
| Stochastic Oscillator | 9.45 | 98.55 |
Price Performance
Historical ComparisonAbout CSGP CoStar Group Inc.
CoStar Group is a global provider of proprietary information, analytics, and online marketplaces serving both commercial and residential real estate. The firm operates through a diverse portfolio of brands, including CoStar Suite for commercial real estate research, LoopNet for commercial listings, Apartments.com for multifamily rentals, and Homes.com for residential brokerage. It primarily sells high-margin software-as-a-service subscriptions that provide institutional clients with forensic property data and premium advertising visibility. With operations across North America, Europe, and Asia-Pacific, CoStar maintains the industry's most comprehensive centralized real estate database, functioning as a critical information utility for brokers, lenders, and owners worldwide.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.